Cryptosporidium Research
Division of Biology
Kansas State University

Updated: 15 November 2004




Nomarski interference contrast photomicrograph of CsCl gradient purified oocysts of Cryptosporidium parvum. Each oocyst measures about 5.2 x 4.6 micrometers and contains four infective sporozoites. Based on these measurements, then the total area covered by an individual oocyst should be about 18.787 square micrometers and the individual volume about 57.613 cubic micrometers. Considering that the specific gravity of oocysts has been calculated at 1.109 using a refractometer, then about 15,651,314,725 oocysts should make a metric gram!

Current areas of research

The parasitology laboratory in the Division of Biology, Kansas State University has been studying the basic and applied biology of Cryptosporidium spp. and other coccidia since 1986. Over 200 papers in refereed journals have originated from the laboratory since that time. In 1991, emphasis was placed on developing a program where expertise from multiple areas could be used collectively to problem solve. Post-doctoral fellows, graduate students, and undergraduates from around the world, with expertise as diverse as molecular biology, biochemistry, immunology, and in vitro cultivation, were selected for their abilities to work together and problem solve. None of these individuals were specialists in coccidian biology, but all received secondary training in that field and were allowed to utilize their previous backgrounds to enhance upon established techniques and dogma. Currently, four individuals are actively engaged in research with expertise in molecular biology, immunology, taxonomy, and in vitro cultivation.


In vitro cultivation/pharmaceutical screening

Recent advances in the ability to cultivate Cryptosporidium parvum in cell culture have allowed for the development of a 96-well ELISA for rapid screening of pharmaceuticals. This system is also useful for studying receptor/ligand interactions. Research on its development was supported almost entirely by Pfizer Animal Health after an NIH study section decided that development of such an ELISA was technically unfeasible. Since that time, our laboratory has tested over 1,500 pharmaceuticals against the parasite using the system. Most recently, the laboratory received an R21 grant from NIH to develop better methods of cultivating the parasite both in vitro and in ovo.

Representative publications

Upton, S.J., M. Tilley, R.R. Mitschler, and B.S. Oppert. 1991. Incorporation of exogenous uracil by Cryptosporidium parvum in vitro. Journal of Clinical Microbiology 29(5): 1062-1065.

Eggleston, M.T., M. Tilley, and S.J. Upton. 1994. Enhanced development of Cryptosporidium parvum in vitro by removal of oocyst toxins from infected cell monolayers. Journal of the Helminthological Society of Washington 61(1): 118-121.

Upton, S.J., M. Tilley, M.V. Nesterenko, and D.B. Brillhart. 1994. A simple and reliable method of producing in vitro infections of Cryptosporidium parvum (Apicomplexa). FEMS Microbiology Letters 118(1-2): 45-50.

Upton, S.J., M. Tilley, and D.B. Brillhart. 1994. Comparative development of Cryptosporidium parvum (Apicomplexa) in 11 continuous host cell lines. FEMS Microbiology Letters 118(3): 233-236.

Upton, S.J., M. Tilley, and D.B. Brillhart. 1994. Comparative development of Cryptosporidium parvum in MDBK and HCT-8 cells under select atmospheres. Biomedical Letters 49(196): 265-271.

Upton, S.J., M. Tilley, and D.B. Brillhart. 1995. Effects of select medium supplements on in vitro development of Cryptosporidium parvum in HCT-8 cells. Journal of Clinical Microbiology 33(2): 371-375.

Woods, K.M., M.V. Nesterenko, and S.J. Upton. 1995. Development of a microtitre ELISA to quantify development of Cryptosporidium parvum in vitro. FEMS Microbiology Letters 128(1): 89-93.

Nesterenko, M.V., K.M.Woods, and S.J. Upton. 1996. Effects of manganese salts on the AIDS-related pathogen, Cryptosporidium parvum in vitro and in vivo. Biological Trace Element Research 56: 243-253.

Woods, K.M., M.V. Nesterenko, and S.J. Upton. 1996. Efficacy of 101 antimicrobials and other agents on development of Cryptosporidium parvum in vitro. Annals of Tropical Medicine and Parasitology 90(6): 603-615.

Upton, S.J. 1997. In vitro cultivation of Cryptosporidium. In: Cryptosporidiosis of Man and Animals, 2nd ed. Chapter 8. (Fayer, R., ed.). CRC Press, Boca Raton. pp. 181-207.

Woods, K.M. and S.J. Upton. 1998. Efficacy of select antivirals against Cryptosporidium parvum in vitro. FEMS Microbiology Letters 168(1): 59-63.

Lindsay, D.S., K.M. Woods, S.J. Upton, and B.L. Blagburn. 2000. Activity of decoquinate against Cryptosporidium parvum in cell cultures and neonatal mice. Vet. Parasitol. 89: 307-311.

Kayser, O., W.R. Waters, K.M. Woods, S.J. Upton, J.S. Keithly, and A.F. Kiderlen. 2001. Evaluation of in vitro activity of aurones and related compounds against Cryptosporidium parvum. Planta Med. 67: 722-725.

Kayser, O., W.R. Waters, K.M. Woods, S.J. Upton, J.S. Keithly, H. Laatsch, and A.F. Kiderlen. 2002. Evaluation of in vitro and in vivo activity of benzindazole-4,9-quinones against Cryptosporidium parvum. J. Antimicrob. Chemother. 50(6): 975-980.


Molecular Biology

In the six years, the parasitology laboratory at Kansas State University has generated complete or partial sequences for over 120 genes from Cryptosporidium parvum. Both genomic and cDNA libraries are used in this research. Additional areas of research and expertise include pulse field mapping of genes to chromosomes, isolation of developmentally regulated genes, and sequencing of extrachromosomal elements. We now know, for instance, that the genome of C. parvum consists of 8 chromosomes with few introns, 2 dsRNA strands of viral origin, and a total of about 10.4 mbp.

Representative publications

Jenkins, M., R. Fayer, M. Tilley, and S.J. Upton. 1993. Cloning and expression of a cDNA encoding epitopes shared by 15-kDa and 60-kilodalton proteins of Cryptosporidium parvum sporozoites. Infection and Immunity 61(6): 2377-2382.

Khramtsov, N.V., M. Tilley, D.S. Blunt, B.A. Montelone, and S.J. Upton. 1995. Cloning and analysis of a Cryptosporidium parvum gene encoding a protein with homology to cytoplasmic form Hsp70. Journal of Eukaryotic Microbiology 42(4): 416-422.

Khramtsov, N.V., D.S. Blunt, B.A. Montelone, and S.J. Upton. 1996. The putative acetyl-CoA synthetase gene of Cryptosporidium parvum and a new conserved protein motif in acetyl-CoA synthetases. Journal of Parasitology 82(3): 423-427.

Blunt, D.S., B.A. Montelone, S.J. Upton, and N.V. Khramtsov. 1996. Sequence of the parasitic protozoan, Cryptosporidium parvum, putative protein disulfide isomerase-encoding DNA. Gene 181: 221-223.

Blunt, D.S., N.V. Khramtsov, S.J. Upton, and B.A. Montelone. 1997. Molecular karyotype analysis of Cryptosporidium parvum: evidence for eight chromosomes and a low-molecular size molecule. Clinical and Diagnostic Laboratory Immunology 4(1): 11-13.

Khramtsov, N.V., B. Oppert, B.A. Montelone, and S.J. Upton. 1997. Sequencing, analysis and expression in Escherichia coli of a gene encoding a 15 kDa Cryptosporidium parvum protein. Biochemical and Biophysical Research Communications 230: 164-166.

Khramtsov, N.V., K.M. Woods, M.V. Nesterenko, C.C. Dykstra, and S.J. Upton. 1997. Virus-like double-stranded RNAs in the pathogenic protozoan, Cryptosporidium parvum. Molecular Microbiology 26(2): 289-300.

LeBlancq, S.M., N.V. Khramtsov, F. Zamani, S.J. Upton, and T.W. Wu. 1997. Ribosomal RNA gene organization in Cryptosporidium parvum. Molecular and Biochemical Parasitology 90: 463-478.

Khramtsov, N.V. and S.J. Upton. 1998. High-temperature inducible cell-free transcription and replication of double-stranded RNAs within the parasitic protozoan Cryptosporidium parvum. Virology 245(2): 331-337.

Woods, K.M., M. Tilley, A. Iseli, S.J. Upton, B.A. Montelone, and N.V. Khramtsov. 1999. Sequence of the gene encoding hsp90e from Cryptosporidium parvum. DNA Sequence 10(4-5): 339-342.

Zhu, G., M.J. Marchewka, K.M. Woods, S.J. Upton and J. S. Keithly. 2000. Molecular analysis of a type I fatty acid synthase in Cryptosporidium parvum. Mol. Biochem. Parasitol. 102(2): 253-260.

Khramtsov, N.V., P.A. Chung, C.C. Dykstra, J.K. Griffiths, U.N. Morgan, M.J. Arrowood, and S.J. Upton. 2000. Presence of dsRNAs in human and calf isolates of Cryptosporidium parvum. J. Parasitol. 86(2): 275-282.

Khramtsov, N.V. and S.J. Upton. 2000. Association of RNA polymerase complexes of the parasitic protozoan Cryptosporidium parvum with virus-like particles: heterogeneous system. J. Virol. 74(13): 5788-5795.

Morgan, U.M., Xiao, L., Monis, P., Sulaiman, I., Pavlasek, I., Blagburn, B., Olson, M., Upton, S.J., Khramtsov, N.V., Lal, A., Elliot, A., and Thompson, R.C.A. 2000. Molecular and phylogenetic analysis of Cryptosporidium muris from various hosts. Parasitology 120: 457-464.

Chung, P.A., J. Kasper, N.V. Khramtsov, and S.J. Upton. 2000. Cloning and molecular characterization of a gene encoding a Cryptosporidium parvum putative 20s proteasone B1-type subunit. DNA Sequence 11(3-4): 309-314.

Khramtsov, N.V. and Upton, S.J. 2003. dsRNAs of Cryptosporidium. J. Parasitol. 89 (suppl.): 165s-168s.

Rochelle, P.A., Fallar, D., Marshall, M.M., Montelone, B.A., Upton, S.J., and Woods, K. 2004. Irreversible UV inactivation of Cryptosporidium spp. despite the presence of UV repair genes. J. Euk. Microbiol. 51(5): 553-562.

Rochelle, P.A., Mofidi, A.A., Marshall, M.M., Upton, S.J., Montelone, B.A., Woods, K., and Di Giovanni, G. 2004. An investigation of UV disinfection and repair in Cryptosporidium parvum. AWWA Research Foundation, Denver, CO. 83 pp.

Rochelle, P.A., Upton, S.J., Montelone, B.A., and Woods, K. 2005. The response of Cryptosporidium parvum to UV light. Trends Parasitol. 21: (in press).


Biochemistry

At least a dozen surface proteins/glycoproteins are known to occur on the surface of Cryptosporidium sporozoites. Research at Kansas State University is actively involved in determining function and kinetics of these surface molecules, especially those interacting with the host cell. Thus far, specific functions have been assigned to five C. parvum surface molecules, and either monoclonal antibodies or polyclonal antiserum have been made to each. Additional areas of biochemical research on this parasite include collaborations on lipid composition and polyamine biosynthetic pathways.

Representative publications

Tilley, M., S.J. Upton, B.L. Blagburn, and B.C. Anderson. 1990. Identification of outer oocyst wall proteins of three species of Cryptosporidium (Apicomplexa: Cryptosporidiidae) by 125I surface labeling. Infection and Immunity 58(1): 252-253.

Tilley, M. and S.J. Upton. 1990. Electrophoretic characterization of Cryptosporidium parvum (KSU-1 isolate) (Apicomplexa: Cryptosporidiidae). Canadian Journal of Zoology 68(7): 1513-1519.

Tilley, M., R. Fayer, A. Guidry, S.J. Upton, and B.L. Blagburn. 1990. Cryptosporidium parvum (Apicomplexa: Cryptosporidiidae) oocyst and sporozoite antigens recognized by bovine colostral antibodies. Infection and Immunity 58(9): 2966-2971.

Tilley, M., S.J. Upton, and P.S. Freed. 1990. A comparative study on the biology of Cryptosporidium serpentis and Cryptosporidium parvum (Apicomplexa: Cryptosporidiidae). Journal of Zoo and Wildlife Medicine 21(4): 463-467.

Tilley, M., S.J. Upton, R. Fayer, J.R. Barta, C.E. Chrisp, P.S. Freed, B.L. Blagburn, B.C. Anderson, and S.M. Barnard. 1991. Identification of a 15 kilodalton surface glycoprotein on sporozoites of Cryptosporidium parvum. Infection and Immunity 59(3): 1002-1007.

Fayer, R., M. Tilley, S.J. Upton, A.J. Guidry, D.W. Thayer, M. Hildreth, and J. Thomson. 1991. Production and preparation of hyperimmune bovine colostrum for passive immunotherapy of cryptosporidiosis. Journal of Protozoology 38(6): 38s-39s.

Tilley, M. and S.J. Upton. 1991. Sporozoites and merozoites of Cryptosporidium parvum share a common epitope recognized by a monoclonal antibody and two-dimensional electrophoresis. Journal of Protozoology 38(6): 48s-49s.

Tilley, M., S.J. Upton, and C.E. Chrisp. 1991. A comparative study on the biology of Cryptosporidium sp. from guinea pigs and Cryptosporidium parvum (Apicomplexa). Canadian Journal of Microbiology 37(12): 949-952.

Tilley, M., M.T. Eggleston, and S.J. Upton. 1993. Multiple oral inoculations with Cryptosporidium parvum as a means of immunization for production of monoclonal antibodies. FEMS Microbiology Letters 113(10): 235-240.

Mitschler, R.R., R. Welti, and S.J. Upton. 1994. A comparative study of lipid compositions of Cryptosporidium parvum (Apicomplexa) and Madin-Darby bovine kidney cells. Journal of Eukaryotic Microbiology 41(1): 8-12.

Tilley, M. and S.J. Upton. 1994. Both CP15 and CP25 are left as trails behind gliding sporozoites of Cryptosporidium parvum (Apicomplexa). FEMS Microbiology Letters 120(3): 275-279.

Nesterenko, M.V., M. Tilley, and S.J. Upton. 1995. A metallo-dependent cysteine proteinase of Cryptosporidium parvum associated with the surface of sporozoites. Microbios 83(2): 77-88.

Yarlett, N., M.P. Martinez, G. Zhu, J.S. Keithly, K. Woods, and S.J. Upton. 1996. Cryptosporidium parvum: polyamine biosynthesis from agamatine. Journal of Eukaryotic Microbiology 43(5): 73s.

Nesterenko, M.V., K.M. Woods, and S.J. Upton. 1997. Effects of manganese salts on the AIDS-related pathogen, Cryptosporidium parvum in vitro and in vivo. Biological Trace Element Research 56(3): 243-253.

Tilley, M. and Upton, S.J. 1997. Biochemistry of Cryptosporidium. In: Cryptosporidiosis of Man and Animals, 2nd ed. Chapter 7. (Fayer, R., ed.). CRC Press, Boca Raton. pp. 163-180.

Keithly, J.S., G.Zhu, S.J. Upton, K.M. Woods, M.P. Martinez, and N. Yarlett. 1997. Polyamine biosynthesis in Cryptosporidium parvum and its implications for chemotherapy. Mol. Biochem. Parasitol. 88: 35-42.

Nesterenko, M.V., K.M. Woods, and S.J. Upton. 1999. Receptor/ligand interactions between Cryptosporidium parvum and the surface of the host cell. Biochimica et Biophysica Acta 1454(2): 165-173.


Wildlife and Zoo parasitology

In addition to the species of Cryptosporidium infecting humans, isolates from wildlife, Zoo and captive specimens are also studied. We hope that, in time, comparing species and isolates both at the structural and molecular levels will aid in determining whether a sample of oocysts collected from surface waters has the potential to infect humans. In collaboration with Auburn University, we obtained a 3-year EPA grant to collect various isolates and species from the environment, make gDNA libraries of each, and deposit these libraries in the American Type Culture Collection. These libraries will prove useful to various investigators who wish to develop species and isolate specific molecular probes.

Representative publications

Upton, S.J. and Current, W.L. 1985. The species of Cryptosporidium (Apicomplexa: Cryptosporidiidae) infecting mammals. Journal of Parasitology 71(5): 625-629.

Current, W.L., S.J. Upton, and T.B. Haynes. 1986. The life cycle of Cryptosporidium baileyi n. sp. (Apicomplexa, Cryptosporidiidae) infecting chickens. Journal of Protozoology 33(2): 289-296.

Upton, S.J. and Barnard, S.M. 1987. Two new species of coccidia (Apicomplexa: Eimeriidae) from Madagascar gekkonids. Journal of Protozoology 34(4): 452-454.

Upton, S.J., M.E. Tilley, G.L. Marchin, and L.R. Fina. 1988. Efficacy of a pentaiodide resin disinfectant on Cryptosporidium parvum (Apicomplexa: Cryptosporidiidae) oocysts in vitro. Journal of Parasitology 74(4): 719-721.

Upton, S.J., C.T., McAllister, P.S. Freed, and S.M. Barnard. 1989. Cryptosporidium spp. in wild and captive reptiles. Journal of Wildlife Diseases 25(1): 20-30.

Upton, S.J., Freed, P.S., Burdick, D.A., and McAllister, C.T. 1990. Seven new species of coccidia (Apicomplexa: Eimeriorina) from reptiles in Madagascar. Canadian Journal of Zoology 68(11): 2368-2375.

Tilley, M., S.J. Upton, B.L. Blagburn, and B.C. Anderson. 1990. Identification of outer oocyst wall proteins of three species of Cryptosporidium (Apicomplexa: Cryptosporidiidae) by 125I surface labeling. Infection and Immunity 58(1): 252-253.

Tilley, M., S.J. Upton, and P.S. Freed. 1990. A comparative study on the biology of Cryptosporidium serpentis and Cryptosporidium parvum (Apicomplexa: Cryptosporidiidae). Journal of Zoo and Wildlife Medicine 21(4): 463-467.

Upton, S.J. 1990. Chapter 10. Cryptosporidiosis in lower vertebrates. In: Cryptosporidiosis in man and animals. Dubey, J.P., Speer, C.A., and Fayer, R., eds. CRC Press, Boca Raton. pp. 149-156.

Todd, S.C., M.S. Phillips, G.L. Marchin, and S.J. Upton. 1991. Cryptosporidium and Giardia in surface waters in and around Manhattan, Kansas. Transactions of the Kansas Academy of Sciences 94(3-4): 101-106.

Tilley, M., S.J. Upton, and C.E. Chrisp. 1991. A comparative study on the biology of Cryptosporidium sp. from guinea pigs and Cryptosporidium parvum (Apicomplexa). Canadian Journal of Microbiology 37(12): 949-952.

Lindsay, D.S., S.J. Upton, D.S. Owens, U.M. Morgan, J.R. Mead, and B.L. Blagburn. 2000. Cryptosporidium andersoni n. sp. (Apicomplexa: Cryptosporiidae) from cattle, Bos taurus. J. Euk. Microbiol. 47(1):91-95.

Fayer, R., U.M. Morgan, and S.J. Upton. 2000. Epidemiology of Cryptosporidium: transmission, detection and identification. Int. J. Parasitol. 30(12-13): 1305-1322.

Duszynski, D.W. and S.J.Upton. 2001. The common coccidia of wild mammals: Cyclospora, Eimeria, Isospora (Eimeriidae) and Cryptosporidium (Cryptosporidiidae). In, Parasitic Diseases of Wild Mammals, 2nd edition. W.M. Samuel and A. Kocan, eds. Wildlife Disease Association, Iowa State University Press, Ames, Iowa. 720 pp.

Palmer, C.J., Xiao, L., Terashima, A., Guerra, H., Gotuzzo, E., Saldias, G., Bonilla, J.A., Zhou, L., Lindquist, A., and Upton, S.J. 2003. Cryptosporidium muris, a rodent pathogen recovered from a human in Peru. Emerg. Inf. Dis. 9: 1174-1176.

Xiao, L., Fayer, R., Ryan, U., and Upton, S.J. 2004. Cryptosporidium taxonomy: recent advances and implications for public health. Clin. Microbiol. Rev. 17(1): 72-97.


Techniques

In addition to more traditional types of basic research, one important area of cryptosporidial research in the Division of Biology has been on the development of novel techniques and assays useful for studying Cryptosporidium spp. These areas of research are typically high risk/high failure, and tend to be supported more from private sources rather than federal funding agencies. However, work on these techniques has allowed for the development of the microtiter ELISA, a rapid silver stain method useful for detecting proteins in SDS-PAGE in under 30 minutes, a rapid (3 minute) sporozoite purification technique, and a rapid sporozoite biotin labeling procedure.

Representative publications

Tilley, M., M.T. Eggleston, and S.J. Upton. 1993. Multiple oral inoculations with Cryptosporidium parvum as a means of immunization for production of monoclonal antibodies. FEMS Microbiology Letters 113(10): 235-240.

Nesterenko, M.V. and S.J. Upton. 1994. A simple modification of Blum's silver stain allows for 30 minute detection of proteins in polyacrylamide gels. Journal of Biochemical and Biophysical Methods 28(2): 239-242.

Woods, K.M., M.V. Nesterenko, and S.J. Upton. 1995. Development of a microtitre ELISA to quantify development of Cryptosporidium parvum in vitro. FEMS Microbiology Letters 128(1): 89-93.

Upton, S.J. and H.H. Gillock. 1996. Infection dynamics of Cryptosporidium parvum in ICR outbred suckling mice. Folia Parasitologica (Praha) 43: 101-106.

Nesterenko, M.V. and S.J. Upton. 1996. A rapid microcentrifuge procedure for purification of Cryptosporidium sporozoites. Journal of Microbiological Methods 25(1): 87-89.

Nesterenko, M.V., K.M. Woods, and S.J. Upton. 1997. Effective nonradioactive method of surface labeling Cryptosporidium parvum sporozoites. Acta Tropica 65(1): 53-57.


For more information concerning Cryptosporidium research in the Division of Biology at Kansas State University, contact:

Steve J. Upton, PhD
Division of Biology, Ackert Hall
Kansas State University
Manhattan, KS 66506


Home | Search | What's New | Help | Comments
Kansas State University | Biology Division